Cambridge New Therapeutics Forum
The purpose of the CamNTF is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance. Spaces are limited, so early registration is encouraged to avoid disappointment.
6pm - Welcome from Host, Astex Pharmaceuticals
- DNA Quadruple Helix - G-Quadruplex by Professor Sir Shankar Balasubramanian, FMedSci, FRS Herchel Smith Professor of Medicinal Chemistry, Department of Chemistry the University of Cambridge, Senior Group Leader at the CRUK Cambridge Institute & Fellow of Trinity College, Cambridge
- Development of the CDK4/6 Inhibitor Ribociclib in Breast Cancer by Dr. Roberta Ferraldeschi, Director, Translational Biology Group, Astex
- Fragment Based Drug Discovery at Astex by Dr. Puja Pathuri, Senior Research Associate, Molecular Sciences Group, Astex
7.10pm - Networking and refreshments
8pm - Close